Piper Sandler analyst Michael Lavery lowered the price target on Procter & Gamble (NYSE: PG) to $142.00 (from $150.00) while maintaining a Neutral rating.

The analyst commented: "PG's exposure to higher resin and other oil derivative costs is more modest compared to its HPC peers at a m.s.d% of COGS (see table, inside note). Its costs are hedged roughly six to nine months out, securing roughly the balance of F26. However, there could be risk to 2027's outlook if elevated oil costs persist. PG's portfolio and brands are compelling, its innovation is ramping up, and US category momentum is improving (now +2.5% vs. +1-2% at end of C25). Momentum outside the US remains good, too, though weakening consumer sentiment remains a key risk globally. We trim our F3Q26E EPS from $1.58 to $1.55 on slightly more conservative top-line assumptions and to better align with tax rate guidance. We maintain our F27 estimates for now, but we trim our multiple from ~20x to ~19x 2027E EPS to better reflect macro uncertainty. We lower our $150 PT to $142."